Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Scynexis Inc

NASDAQ: SCYX · Life Sciences · 3 alerts · CIK 1178253

Share price
$2.91Close, Nov 16
Market cap
$29M
Shares outstanding
9.95MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Scynexis Inc filings on SEC EDGAR ↗

8:06 AM ET 8-K
Executive Compensation

Scynexis Executive Compensation

SCYNEXIS appointed Steven K. Burke, M.D., to its Board of Directors and the Nominating and Corporate Governance Committee. Dr. Burke will receive an annual cash retainer of $45,000 plus $5,000 for committee service, along with initial equity grants of 5,750 stock options and 5,750 restricted stock units. The appointment adds deep nephrology drug development expertise as the company prepares to advance its ADPKD candidate, SCY-770, into Phase 2 trials.

Counterparty
Steven K. Burke, M.D.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.